AGIOS PHARMACEUTICALS, INC.
Biopharmaceutical company developing therapies for rare and genetically defined diseases.
AGIO | US
Overview
Corporate Details
- ISIN(s):
- US00847X1046
- LEI:
- Country:
- United States of America
- Address:
- 88 SIDNEY STREET, 2139 CAMBRIDGE
- Website:
- https://www.agios.com/
- Sector:
- Manufacturing
Description
Agios Pharmaceuticals is a commercial-stage biopharmaceutical company that develops therapies for rare and genetically defined diseases. The company leverages its expertise in the science of cellular metabolism to discover and advance new treatments. Its near-term therapeutic focus is on hemolytic and acquired anemias. The company's lead medicine is PYRUKYND® (mitapivat), a first-in-class pyruvate kinase activator. Agios aims to establish a portfolio of disease-modifying therapies that provide long-term effects for patients with significant unmet medical needs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all AGIOS PHARMACEUTICALS, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for AGIOS PHARMACEUTICALS, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for AGIOS PHARMACEUTICALS, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
